001     633348
005     20250810054046.0
024 7 _ |a 10.1007/s00401-025-02859-6
|2 doi
024 7 _ |a 0001-6322
|2 ISSN
024 7 _ |a 1432-0533
|2 ISSN
024 7 _ |a openalex:W4408219056
|2 openalex
024 7 _ |a 10.3204/PUBDB-2025-02394
|2 datacite_doi
024 7 _ |a altmetric:174940095
|2 altmetric
024 7 _ |a pmid:40042537
|2 pmid
037 _ _ |a PUBDB-2025-02394
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Abdeen, Amr H.
|b 0
245 _ _ |a Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
260 _ _ |a Heidelberg
|c 2025
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1754467157_2660921
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Atypical wild-type superoxide dismutase 1 (SOD1) protein misfolding and deposition occurs specifically within the degenerating substantia nigra pars compacta (SNc) in Parkinson disease. Mechanisms driving the formation of this pathology and relationship with SNc dopamine neuron health are yet to be fully understood. We applied proteomic mass spectrometry and synchrotron-based biometal quantification to post-mortem brain tissues from the SNc of Parkinson disease patients and age-matched controls to uncover key factors underlying the formation of wild-type SOD1 pathology in this disorder. We also engineered two of these factors - brain copper deficiency and upregulated SOD1 protein levels - into a novel mouse strain, termed the SOCK mouse, to verify their involvement in the development of Parkinson-like wild-type SOD1 pathology and their impact on dopamine neuron health. Soluble SOD1 protein in the degenerating Parkinson disease SNc exhibited altered post-translational modifications, which may underlie changes to the enzymatic activity and aggregation of the protein in this region. These include decreased copper binding, dysregulation of physiological glycosylation, and atypical oxidation and glycation of key SOD1 amino acid residues. We demonstrated that the biochemical profile introduced in SOCK mice promotes the same post-translational modifications and the development of Parkinson-like wild-type SOD1 pathology in the midbrain and cortex. This pathology accumulates progressively with age and is accompanied by nigrostriatal degeneration and dysfunction, which occur in the absence of α-synuclein deposition. These mice do not exhibit weight loss nor spinal cord motor neuron degeneration, distinguishing them from transgenic mutant SOD1 mouse models. This study provides the first in vivo evidence that mismetallation and altered post-translational modifications precipitates wild-type SOD1 misfolding, dysfunction, and deposition in the Parkinson disease brain, which may contribute to SNc dopamine neuron degeneration. Our data position this pathology as a novel drug target for this disorder, with a particular focus on therapies capable of correcting alterations to SOD1 post-translational modifications.
536 _ _ |a 633 - Life Sciences – Building Blocks of Life: Structure and Function (POF4-633)
|0 G:(DE-HGF)POF4-633
|c POF4-633
|f POF IV
|x 0
536 _ _ |a 6G3 - PETRA III (DESY) (POF4-6G3)
|0 G:(DE-HGF)POF4-6G3
|c POF4-6G3
|f POF IV
|x 1
536 _ _ |a FS-Proposal: I-20230761 EC (I-20230761-EC)
|0 G:(DE-H253)I-20230761-EC
|c I-20230761-EC
|x 2
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |a PETRA III
|f PETRA Beamline P06
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P06-20150101
|6 EXP:(DE-H253)P-P06-20150101
|x 0
700 1 _ |a Trist, Benjamin G.
|b 1
700 1 _ |a Nikseresht, Sara
|b 2
700 1 _ |a Harwood, Richard
|b 3
700 1 _ |a Roudeau, Stéphane
|0 P:(DE-H253)PIP1031511
|b 4
700 1 _ |a Rowlands, Benjamin D.
|b 5
700 1 _ |a Kreilaus, Fabian
|b 6
700 1 _ |a Cottam, Veronica
|b 7
700 1 _ |a Mor, David
|b 8
700 1 _ |a Richardson, Miriam
|b 9
700 1 _ |a Siciliano, Joel
|b 10
700 1 _ |a Forkgen, Julia
|b 11
700 1 _ |a Schaffer, Greta
|b 12
700 1 _ |a Genoud, Sian
|b 13
700 1 _ |a Li, Anne A.
|b 14
700 1 _ |a Proschogo, Nicholas
|b 15
700 1 _ |a Antonio, Bernadeth
|b 16
700 1 _ |a Falkenberg, Gerald
|0 P:(DE-H253)PIP1002716
|b 17
700 1 _ |a Brueckner, Dennis
|0 P:(DE-H253)PIP1021825
|b 18
700 1 _ |a Kysenius, Kai
|b 19
700 1 _ |a Liddell, Jeffrey R.
|b 20
700 1 _ |a Fat, Sandrine Chan Moi
|b 21
700 1 _ |a Wu, Sharlynn
|b 22
700 1 _ |a Fifita, Jennifer
|b 23
700 1 _ |a Lockwood, Thomas E.
|b 24
700 1 _ |a Bishop, David P.
|b 25
700 1 _ |a Blair, Ian
|b 26
700 1 _ |a Ortega, Richard
|0 P:(DE-H253)PIP1010711
|b 27
700 1 _ |a Crouch, Peter J.
|b 28
700 1 _ |a Double, Kay
|0 P:(DE-H253)PIP1085626
|b 29
|e Corresponding author
773 _ _ |a 10.1007/s00401-025-02859-6
|g Vol. 149, no. 1, p. 22
|0 PERI:(DE-600)1458410-4
|n 1
|p 22
|t Acta neuropathologica
|v 149
|y 2025
|x 0001-6322
856 4 _ |y OpenAccess
|u https://bib-pubdb1.desy.de/record/633348/files/2025Abdeen%28Acta%20Neuropathologica%29.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://bib-pubdb1.desy.de/record/633348/files/2025Abdeen%28Acta%20Neuropathologica%29.pdf?subformat=pdfa
909 C O |o oai:bib-pubdb1.desy.de:633348
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 4
|6 P:(DE-H253)PIP1031511
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 17
|6 P:(DE-H253)PIP1002716
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 18
|6 P:(DE-H253)PIP1021825
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 27
|6 P:(DE-H253)PIP1010711
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 29
|6 P:(DE-H253)PIP1085626
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|1 G:(DE-HGF)POF4-630
|0 G:(DE-HGF)POF4-633
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v Life Sciences – Building Blocks of Life: Structure and Function
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Großgeräte: Materie
|1 G:(DE-HGF)POF4-6G0
|0 G:(DE-HGF)POF4-6G3
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v PETRA III (DESY)
|x 1
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-11
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ACTA NEUROPATHOL : 2022
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-11
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2024-12-11
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-11
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL : 2022
|d 2024-12-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-11
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-11
920 1 _ |0 I:(DE-H253)HAS-User-20120731
|k DOOR ; HAS-User
|l DOOR-User
|x 0
920 1 _ |0 I:(DE-H253)FS-PET-S-20190712
|k FS-PET-S
|l Experimentebetreuung PETRA III
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)HAS-User-20120731
980 _ _ |a I:(DE-H253)FS-PET-S-20190712
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21